Evidence map›Paper›PMID 38953631›Full record

ArticleJournal of virology2024

Characterization of human tibrovirus envelope glycoproteins.

Yannick Munyeku-Bazitama, Takeshi Saito, Takanari Hattori, Hiroko Miyamoto, Boniface Pongombo Lombe, Akina Mori-Kajihara, Masahiro Kajihara, Jean-Jacques Muyembe-Tamfum, Manabu Igarashi, Eun-Sil Park and 3 more

Abstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yannick Munyeku-BazitamaDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.ORCID 0000-0001-8303-318X
Takeshi SaitoDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Takanari HattoriDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Hiroko MiyamotoDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Boniface Pongombo LombeDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Akina Mori-KajiharaDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Masahiro KajiharaDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Jean-Jacques Muyembe-TamfumInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Manabu IgarashiDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Eun-Sil ParkDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Shigeru MorikawaDepartment of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan.
Sheila Makiala-MandandaInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Ayato TakadaDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.ORCID 0000-0003-2464-6642

Funding

Japan Agency for Medical Research and Development (AMED) JP23fk0108624Japan Agency for Medical Research and Development (AMED) JP23jm0110019Japan Agency for Medical Research and Development (AMED) JP23wm0125008
6 · The paper itself

Abstract

Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%-48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses. IMPORTANCE: Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies.

Indexed as

Viral Envelope ProteinsAmino Acid SequenceAnimalsAntibodies, ViralCell LineGlycosylationHEK293 CellsHumansMiceMucin-1Viral TropismVirus InternalizationAntibodies, ViralMUC1 protein, humanMucin-1Viral Envelope ProteinsBas-Congo virusEkpoma virus 1Ekpoma virus 2glycoproteinMundri virusTibrogargan virustibrovirus

Identifiers

PMID38953631
PMCPMC11265436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.